Products

R1762-1 - DDX17 (N) Antibody, Rabbit Polyclonal

Catalog No. R1762-1
Product Name DDX17 (N) Antibody, Rabbit Polyclonal
Price $249
  
 

Quantity: 100 ul                                                                                          Application: WB, IP

Predicted I Observed M.W.: 80 kDa                                                            Uniprot ID: Q92841


Background:

Probable ATP-dependent RNA helicase DDX17 belongs to the DEAD box helicase family and the DDX5/DBP2 subfamily. DDX17 is an RNA-dependent ATPase activity. DDX17 is involved in transcriptional regulation and is a transcriptional coactivator for estrogen receptor ESR1. DDX17 increases ESR1 AF-1 domain-mediated transactivation. Additionally, DDX17 synergizes with DDX5 and SRA1 RNA to activate MYOD1 transcriptional activity and is probably involved in skeletal muscle differentiation. Furthermore, DDX17 is required for zinc-finger antiviral protein ZC3HAV1-mediated mRNA degradation.

Other Names:

Probable ATP-dependent RNA helicase DDX17, DEAD box protein 17, DEAD box protein p72, RNA-dependent helicase p72

Source and Purity:

Rabbit polyclonal antibodies were produced by immunizing animals with a GST-fusion protein containing the N-terminal region of human DDX17. Antibodies were purified by affinity purification using immunogen. 

Storage Buffer and Condition:

Supplied in 1 x PBS (pH 7.4), 100 ug/ml BSA, 40% Glycerol, 0.01% NaN3. Store at -20 °C. Stable for 6 months from date of receipt.

Species Specificity:

Human, Mouse

Tested Applications:

WB: 1:1,000-1:3,000 (detect endogenous protein*)

IP: 1:100-1:200

*: The apparent protein size on WB may be different from the calculated M.W. due to modifications.

Product Data:

DDX17 Western Antibody (Abiocode)

Fig 1. (A) Western blot of total cell extracts from a. mouse brain, b. mouse thymus,
c, e. human HeLa, d, f. human Jurkat; using 2 independent Abs against 2 distinct
regions of human DDX17 at RT for 2 h. (B) Total extracts from human HeLa were
immunoprecipitated (IP) with IgG or anti-DDX17 (N) (R1762-1); followed by WB
with the same Ab.